Search Results - "Iurilli, Valentina"
-
1
Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics
Published in Pharmaceuticals (Basel, Switzerland) (17-01-2022)“…In the treatment of pediatric diseases, mass-produced dosage forms are often not suitable for children. Commercially available medicines are commonly…”
Get full text
Journal Article -
2
AmBisome ® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
Published in Pharmaceutics (01-04-2024)“…Liposomal amphotericin B (Ambisome ) is the gold standard for the treatment and prevention of fungal infections both in the adult and pediatric populations…”
Get full text
Journal Article -
3
Early molecular diagnosis of BRAF status drives the neurosurgical management in BRAF V600E-mutant pediatric low-grade gliomas: a case report
Published in BMC pediatrics (29-11-2022)“…To date, this is the only report showing with close and consecutive magnetic resonance images the extremely rapid response of two types of pediatric low-grade…”
Get full text
Journal Article -
4
The role of pharmacies in haematopoietic stem cell transplantation process: A nationwide survey by Gruppo Italiano Trapianto di Midollo Osseo
Published in Journal of clinical pharmacy and therapeutics (01-12-2021)“…What is known and objective The aim of this survey, conducted by the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), was to evaluate the involvement…”
Get full text
Journal Article -
5
LGG-40. Growth hormone replacement in children on therapy with Vemurafenib for Low Grade Glioma
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract BRAF inhibitors (iBRAF) are a therapeutical option for pediatric Low-Grade-Gliomas (pLGG), but their chronic use may be needed to prevent tumor…”
Get full text
Journal Article -
6
SURG-07. The impact of early targeted therapy on the neurosurgical approach to pediatric low-grade glioma
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract We report two cases of pediatric low-grade glioma (pLGG) treated with vemurafenib, an oral BRAF-inhibitor: a 12-year-old girl with involvement of…”
Get full text
Journal Article -
7
LGG-35. Dyslipidemia in children treated with BRAF inhibitors for brain tumor, a new side effect? A single center retrospective study
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract The targeted therapies for brain tumors are innovative and promising oncological treatments and as a result their use has expanded widely. BRAF…”
Get full text
Journal Article -
8
LGG-34. Nephrological impact of BRAF inhibitors in a pediatric population of central nervous system tumors: a single institution experience
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract BRAF inhibitors (iBRAF) are under investigations in ongoing clinical trials for pediatric brain tumor treatment. Preliminary data regarding the…”
Get full text
Journal Article -
9
Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect?
Published in Cancers (29-05-2022)“…BRAF inhibitors, in recent years, have played a central role in the disease control of unresectable BRAF-mutated pediatric low-grade gliomas (LGGs). The aim of…”
Get full text
Journal Article -
10
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience
Published in Neuromuscular disorders : NMD (01-12-2017)Get full text
Journal Article -
11
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues
Published in European journal of paediatric neurology (01-07-2018)Get full text
Journal Article